Nifty
:
24213.30
Sensex
:
79476.63
217.95 (0.91%)
694.39 (0.88%)
Nifty
Sensex
:
:
24213.30
79476.63
217.95 (0.91%)
694.39 (0.88%)

Aarti Drugs Ltd.

Pharmaceuticals & Drugs - API

Rating :
N/A

BSE: 524348 | NSE: AARTIDRUGS

NSE BSE
554.45
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  532.50
  •  557.00
  •  532.50
  •  535.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  392716
  •  2148.77
  •  635.00
  •  431.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,428.88
  • 29.08
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 5,002.87
  • 0.21%
  • 3.47

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.64%
  • 1.06%
  • 24.80%
  • FII
  • DII
  • Others
  • 2.5%
  • 6.33%
  • 9.67%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.71
  • 6.96
  • 0.53

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.41
  • 3.86
  • -0.72

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.30
  • 3.93
  • -5.79

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.79
  • 23.53
  • 24.03

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.03
  • 4.65
  • 3.90

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 12.81
  • 14.81
  • 15.25

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
598.33
641.54
-6.74%
555.34
661.11
-16.00%
619.99
742.41
-16.49%
605.94
663.96
-8.74%
Expenses
531.28
565.09
-5.98%
490.38
577.04
-15.02%
534.18
648.87
-17.68%
535.80
593.31
-9.69%
EBITDA
67.05
76.45
-12.30%
64.96
84.07
-22.73%
85.81
93.54
-8.26%
70.14
70.65
-0.72%
EBIDTM
11.21%
11.92%
11.70%
12.72%
13.84%
12.60%
11.58%
10.64%
Other Income
1.48
0.68
117.65%
1.11
0.60
85.00%
1.08
0.87
24.14%
1.67
1.01
65.35%
Interest
8.93
8.25
8.24%
8.71
8.54
1.99%
9.13
8.63
5.79%
7.60
9.36
-18.80%
Depreciation
13.72
12.61
8.80%
13.38
12.60
6.19%
13.58
12.50
8.64%
12.66
12.62
0.32%
PBT
45.88
56.27
-18.46%
43.98
63.53
-30.77%
64.18
73.28
-12.42%
51.55
49.68
3.76%
Tax
10.92
16.67
-34.49%
10.71
15.56
-31.17%
16.87
17.10
-1.35%
14.84
13.01
14.07%
PAT
34.96
39.60
-11.72%
33.27
47.97
-30.64%
47.31
56.18
-15.79%
36.71
36.67
0.11%
PATM
5.84%
6.17%
5.99%
7.26%
7.63%
7.57%
6.06%
5.52%
EPS
3.84
4.31
-10.90%
3.62
5.17
-29.98%
5.15
6.06
-15.02%
3.99
3.96
0.76%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
2,379.60
2,528.58
2,716.05
2,488.65
2,154.78
1,806.09
1,560.94
1,243.63
1,195.17
1,139.84
1,096.88
Net Sales Growth
-12.16%
-6.90%
9.14%
15.49%
19.31%
15.71%
25.51%
4.05%
4.85%
3.92%
 
Cost Of Goods Sold
1,556.16
1,605.15
1,813.56
1,614.49
1,263.35
1,127.29
1,013.53
737.72
744.43
735.08
724.24
Gross Profit
823.44
923.42
902.50
874.15
891.43
678.79
547.40
505.91
450.75
404.77
372.65
GP Margin
34.60%
36.52%
33.23%
35.13%
41.37%
37.58%
35.07%
40.68%
37.71%
35.51%
33.97%
Total Expenditure
2,091.64
2,207.74
2,406.60
2,156.05
1,714.40
1,540.57
1,350.03
1,041.76
1,004.68
960.02
924.51
Power & Fuel Cost
-
154.31
156.10
128.34
98.20
103.83
84.39
71.42
59.42
53.93
49.56
% Of Sales
-
6.10%
5.75%
5.16%
4.56%
5.75%
5.41%
5.74%
4.97%
4.73%
4.52%
Employee Cost
-
90.60
80.43
69.30
65.88
61.35
54.55
52.14
47.95
40.19
33.26
% Of Sales
-
3.58%
2.96%
2.78%
3.06%
3.40%
3.49%
4.19%
4.01%
3.53%
3.03%
Manufacturing Exp.
-
252.91
241.58
230.56
181.41
160.38
142.69
130.01
103.21
87.60
75.53
% Of Sales
-
10.00%
8.89%
9.26%
8.42%
8.88%
9.14%
10.45%
8.64%
7.69%
6.89%
General & Admin Exp.
-
29.50
28.79
30.42
29.03
21.39
14.24
12.22
12.81
10.98
10.48
% Of Sales
-
1.17%
1.06%
1.22%
1.35%
1.18%
0.91%
0.98%
1.07%
0.96%
0.96%
Selling & Distn. Exp.
-
63.79
75.54
73.99
70.99
59.46
37.51
34.00
31.16
27.82
28.99
% Of Sales
-
2.52%
2.78%
2.97%
3.29%
3.29%
2.40%
2.73%
2.61%
2.44%
2.64%
Miscellaneous Exp.
-
11.48
10.61
8.95
5.54
6.88
3.11
4.24
5.71
4.42
28.99
% Of Sales
-
0.45%
0.39%
0.36%
0.26%
0.38%
0.20%
0.34%
0.48%
0.39%
0.22%
EBITDA
287.96
320.84
309.45
332.60
440.38
265.52
210.91
201.87
190.49
179.82
172.37
EBITDA Margin
12.10%
12.69%
11.39%
13.36%
20.44%
14.70%
13.51%
16.23%
15.94%
15.78%
15.71%
Other Income
5.34
4.03
2.19
11.32
4.53
1.48
2.41
1.05
4.00
0.00
0.65
Interest
34.37
37.89
37.14
23.91
26.23
37.42
43.51
38.36
40.02
48.02
42.28
Depreciation
53.34
51.45
50.32
50.05
49.88
48.75
42.56
40.06
38.46
36.53
31.02
PBT
205.59
235.53
224.18
269.96
368.79
180.82
127.26
124.50
116.01
95.27
99.72
Tax
53.34
63.94
57.82
64.96
88.62
43.89
41.27
42.20
34.21
26.55
22.47
Tax Rate
25.94%
27.15%
25.79%
24.06%
24.02%
23.69%
31.50%
33.90%
29.49%
27.87%
22.53%
PAT
152.25
171.42
166.31
205.04
280.41
141.40
89.75
82.31
81.80
68.72
77.25
PAT before Minority Interest
152.29
171.59
166.36
205.00
280.40
141.40
89.75
82.31
81.80
68.72
77.25
Minority Interest
0.04
-0.17
-0.05
0.04
0.01
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
6.40%
6.78%
6.12%
8.24%
13.01%
7.83%
5.75%
6.62%
6.84%
6.03%
7.04%
PAT Growth
-15.61%
3.07%
-18.89%
-26.88%
98.31%
57.55%
9.04%
0.62%
19.03%
-11.04%
 
EPS
16.68
18.78
18.22
22.46
30.71
15.49
9.83
9.02
8.96
7.53
8.46

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
1,281.55
1,192.43
1,036.36
913.42
652.49
543.45
455.43
400.13
357.40
308.15
Share Capital
91.94
92.60
92.60
93.20
23.30
23.58
23.58
23.86
24.22
24.22
Total Reserves
1,189.61
1,099.83
943.76
820.22
629.19
519.86
431.85
376.27
333.18
283.94
Non-Current Liabilities
354.86
279.25
231.60
257.25
300.82
321.06
312.31
296.59
243.78
211.03
Secured Loans
271.76
196.11
129.93
138.99
171.74
199.64
190.53
187.38
176.66
152.72
Unsecured Loans
3.57
8.57
8.57
8.57
8.57
8.57
12.17
14.17
14.57
10.75
Long Term Provisions
2.74
3.03
9.23
21.67
25.13
12.32
16.87
8.39
1.42
0.29
Current Liabilities
795.54
949.48
940.06
595.36
623.19
590.98
621.68
494.31
501.02
482.76
Trade Payables
425.49
480.27
468.67
329.97
329.55
242.63
258.73
196.97
184.90
166.72
Other Current Liabilities
151.21
100.07
111.33
105.38
132.83
82.94
56.42
51.00
43.80
41.53
Short Term Borrowings
214.70
360.55
356.34
157.21
157.73
263.25
305.64
244.66
258.41
252.43
Short Term Provisions
4.13
8.60
3.71
2.80
3.08
2.16
0.89
1.68
13.91
22.08
Total Liabilities
2,432.36
2,421.39
2,207.96
1,766.01
1,576.50
1,455.49
1,389.42
1,191.03
1,102.20
1,001.94
Net Block
811.09
676.23
689.93
665.40
643.81
624.86
602.39
581.09
493.42
448.46
Gross Block
1,388.16
1,202.18
1,169.00
1,101.02
1,030.97
970.09
909.20
848.13
725.47
685.21
Accumulated Depreciation
577.07
525.96
479.06
435.62
387.16
345.22
306.81
267.04
232.05
236.75
Non Current Assets
1,111.64
929.61
814.59
709.22
672.50
671.20
652.55
619.61
536.97
476.40
Capital Work in Progress
260.87
210.35
76.74
19.26
12.21
32.75
28.45
14.28
34.04
16.06
Non Current Investment
19.97
18.80
19.48
17.30
13.36
12.44
10.76
11.94
4.63
4.63
Long Term Loans & Adv.
19.70
24.23
28.44
7.26
3.12
1.15
10.95
12.30
4.88
7.24
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
1,320.72
1,491.79
1,393.37
1,056.80
904.00
784.29
736.86
571.42
565.23
525.54
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
485.89
516.29
525.94
415.00
325.40
246.61
278.21
209.63
178.35
164.20
Sundry Debtors
704.55
864.84
749.90
555.23
488.63
458.54
374.94
296.81
331.69
314.27
Cash & Bank
9.43
8.96
22.33
9.78
7.64
5.55
4.27
4.17
4.82
3.58
Other Current Assets
120.84
3.04
0.70
2.44
82.32
73.58
79.44
60.81
50.37
43.49
Short Term Loans & Adv.
117.61
98.66
94.50
74.35
75.50
67.02
69.23
60.81
50.37
43.49
Net Current Assets
525.18
542.31
453.31
461.44
280.81
193.31
115.19
77.11
64.20
42.78
Total Assets
2,432.36
2,421.40
2,207.96
1,766.02
1,576.50
1,455.49
1,389.41
1,191.03
1,102.20
1,001.94

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
358.92
133.32
70.41
154.95
250.74
143.09
69.77
174.75
133.29
104.59
PBT
235.53
224.18
269.96
369.01
185.29
131.02
124.50
116.01
95.27
99.72
Adjustment
83.01
85.15
71.19
68.60
86.84
75.20
75.12
71.63
79.30
69.40
Changes in Working Capital
102.78
-116.34
-187.35
-185.99
19.49
-33.49
-105.19
8.47
-21.25
-49.58
Cash after chg. in Working capital
421.32
193.00
153.79
251.63
291.62
172.74
94.44
196.11
153.33
119.53
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-62.40
-59.67
-83.38
-96.68
-40.88
-29.64
-24.67
-21.36
-20.03
-14.94
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-223.65
-163.97
-149.64
-71.78
-33.21
-61.67
-73.54
-106.98
-98.79
-107.01
Net Fixed Assets
-196.35
-130.20
-103.41
-70.18
-45.34
-62.81
-72.64
-92.88
-46.34
-322.27
Net Investments
-1.35
-0.59
-3.71
-3.94
-1.46
-1.68
1.18
-7.30
-0.01
13.50
Others
-25.95
-33.18
-42.52
2.34
13.59
2.82
-2.08
-6.80
-52.44
201.76
Cash from Financing Activity
-136.03
16.54
92.03
-81.13
-215.41
-80.07
3.92
-68.23
-33.26
1.46
Net Cash Inflow / Outflow
-0.76
-14.11
12.80
2.04
2.13
1.35
0.15
-0.45
1.24
-0.95
Opening Cash & Equivalents
7.50
21.61
8.81
6.77
4.64
3.29
3.15
3.60
3.58
4.53
Closing Cash & Equivalent
6.74
7.50
21.61
8.81
6.77
4.64
3.29
3.15
4.82
3.58

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
139.40
128.77
111.92
98.01
70.01
57.61
48.28
41.93
36.90
31.81
ROA
7.07%
7.19%
10.32%
16.78%
9.33%
6.31%
6.38%
7.13%
6.53%
10.13%
ROE
13.87%
14.93%
21.03%
35.81%
23.65%
17.97%
19.24%
21.60%
20.65%
32.78%
ROCE
15.01%
15.49%
20.75%
34.52%
21.39%
17.01%
17.31%
18.50%
18.33%
23.93%
Fixed Asset Turnover
1.95
2.29
2.19
2.02
1.81
1.66
1.44
1.64
1.75
2.19
Receivable days
113.27
108.50
95.71
88.41
95.71
97.45
97.10
89.05
95.59
67.25
Inventory Days
72.33
70.03
69.00
62.71
57.80
61.36
70.52
54.97
50.69
39.52
Payable days
102.98
95.49
90.28
95.27
64.68
68.08
73.82
67.66
65.68
45.51
Cash Conversion Cycle
82.62
83.04
74.43
55.85
88.83
90.73
93.79
76.36
80.60
61.26
Total Debt/Equity
0.44
0.51
0.52
0.38
0.58
0.93
1.20
1.20
1.26
1.45
Interest Cover
7.22
7.04
12.29
15.07
5.95
4.01
4.25
3.90
2.98
3.36

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012

News Update:


  • Aarti Drugs - Quarterly Results
    24th Oct 2024, 18:04 PM

    Read More
  • Aarti Drugs gets GMP certificate from UK MHRA
    4th Oct 2024, 11:00 AM

    The company has received GMP Certificate for manufacturing facility of its subsidiary - (Pinnacle Life Science) located at Baddi, Himachal Pradesh

    Read More
  • USFDA completes inspection at Aarti Drugs’ API manufacturing facility
    21st Sep 2024, 10:08 AM

    USFDA conducted inspection from September 12, 2024 to September 20, 2024

    Read More
  • USFDA issues EIR to Baddi facility of Aarti Drugs’ arm
    30th Jul 2024, 11:41 AM

    USFDA conducted inspection from April 16, 2024 to April 22, 2024

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.